The U.S. Agency for International Development and the International Disease Research Institute, a U.S.-based nonprofit organization, have agreed to jointly support the development of a new vaccine to fight malaria.
Under a memorandum of agreement, the two agencies will collaborate with the Walter Reed Army Institute of Research for the clinical trial of a malaria vaccine candidate that combines an antigen developed by WRAIR with IDRI’s potent immunological agent.
Read more on U.S. aid reform online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.
